Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takanori Yamamoto

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Calcium|February 29, 2012
[Evidence for osteoporosis treatment using PTH (1-34) daily subcutaneous injection]Takanori Yamamoto, Etsuro Hamaya, Hideaki Sowa
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 12, 2022
Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical recordsYuki Asai, Takanori Yamamoto, Yoshiharu Sato
Clinical Calcium|December 29, 2010
[Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection]Hideaki Sowa, Etsuro Hamaya, Takanori Yamamoto
Clinical Interventions in Aging|July 18, 2015
Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevationTakanori Yamamoto, Mika Tsujimoto, Hideaki Sowa
International Journal of Toxicology|October 18, 2021
Evaluation of the Expression Profile of Antibiotic-Induced Thrombocytopenia Using the Japanese Adverse Drug Event Report DatabaseYuki Asai, Takanori Yamamoto, Yasuharu Abe
Journal of Thermal Biology|March 17, 2015
Thermal responses and perceptions under distinct ambient temperature and wind conditionsYasuhiro Shimazaki, Atsumasa Yoshida, Takanori Yamamoto
Journal of Clinical Pharmacology|August 7, 2022
Exploratory Study of Pharmacists' Monitoring Methods Based on Left Ventricular Function for Hypermagnesemia by Magnesium Oxide in Heart FailureYuki Asai, Tatsuki Yanagawa, Takanori Yamamoto, et al.
Health Security|August 4, 2021
Assessment of Critical Care Surge Capacity During the COVID-19 Pandemic in JapanTakanori Yamamoto, Masayuki Ozaki, Daisuke Kasugai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 31, 2022
[Evaluation of Disopyramide Efficacy for Refractory Syncope in Heart Failure with Preserved Ejection Fraction Using Holter Electrocardiography: A Case Report]Yuki Asai, Takuya Shintani, Takanori Yamamoto, et al.
Journal of Bone and Mineral Metabolism|November 9, 2012
Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosisTakanori Yamamoto, Mika Tsujimoto, Etsuro Hamaya, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Calcium|February 29, 2012
[Evidence for osteoporosis treatment using PTH (1-34) daily subcutaneous injection]Takanori Yamamoto, Etsuro Hamaya, Hideaki Sowa
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 12, 2022
Risk assessment of micafungin-induced liver injury using spontaneous reporting system data and electronic medical recordsYuki Asai, Takanori Yamamoto, Yoshiharu Sato
Clinical Calcium|December 29, 2010
[Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection]Hideaki Sowa, Etsuro Hamaya, Takanori Yamamoto
Clinical Interventions in Aging|July 18, 2015
Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevationTakanori Yamamoto, Mika Tsujimoto, Hideaki Sowa
International Journal of Toxicology|October 18, 2021
Evaluation of the Expression Profile of Antibiotic-Induced Thrombocytopenia Using the Japanese Adverse Drug Event Report DatabaseYuki Asai, Takanori Yamamoto, Yasuharu Abe
Journal of Thermal Biology|March 17, 2015
Thermal responses and perceptions under distinct ambient temperature and wind conditionsYasuhiro Shimazaki, Atsumasa Yoshida, Takanori Yamamoto
Journal of Clinical Pharmacology|August 7, 2022
Exploratory Study of Pharmacists' Monitoring Methods Based on Left Ventricular Function for Hypermagnesemia by Magnesium Oxide in Heart FailureYuki Asai, Tatsuki Yanagawa, Takanori Yamamoto, et al.
Health Security|August 4, 2021
Assessment of Critical Care Surge Capacity During the COVID-19 Pandemic in JapanTakanori Yamamoto, Masayuki Ozaki, Daisuke Kasugai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 31, 2022
[Evaluation of Disopyramide Efficacy for Refractory Syncope in Heart Failure with Preserved Ejection Fraction Using Holter Electrocardiography: A Case Report]Yuki Asai, Takuya Shintani, Takanori Yamamoto, et al.
Journal of Bone and Mineral Metabolism|November 9, 2012
Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosisTakanori Yamamoto, Mika Tsujimoto, Etsuro Hamaya, et al.
Pageof 5